儿童肺炎支原体肺炎诊治的专家释疑(2023年11月)  

Interpretation of key points in diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children(November 2023)

作　　者：赵顺英[1] 刘瀚旻[2] 陆权 刘玺诚[1] 洪建国[4] 刘恩梅[5] 邹映雪[6] 杨梅 陈志敏[8] 张海邻[9] 赵德育[10] 张晓波 殷勇[12] 董晓艳 陆小霞 刘金荣[1] 陈莉娜[2] Zhao Shunying;Liu Hanmin;Lu Quan;Liu Xicheng;Hong Jianguo;Liu Enmei;Zou Yingxue;Yang Mei;Chen Zhimin;Zhang Hailin;Zhao Deyu;Zhang Xiaobo;Yin Yong;Dong Xiaoyan;Lu Xiaoxia;Liu Jinrong;Chen Lina(Department of No.2 Respiratory Medicine,Beijing Children′s Hospital,Capital Medical University,National Clinical Research Center for Respiratory Diseases,National Center for Children′s Health,Beijing 100045,China;Department of Pediatric Pulmonology and Immunology,West China Second University Hospital,Sichuan University,Chengdu 610041,China;Department of Pulmonology,Shanghai Children′s Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200062,China;Department of Pediatrics,Shanghai General Hospital,Shanghai Jiao Tong University,School of Medicine,Shanghai 200080,China;Department of Respiratory,Children′s Hospital of Chongqing Medical University,Chongqing 400014,China;Department of Pulmonology,Tianjin Children′s Hospital(Children′s Hospital of Tianjin University),Machang Compus,Tianjin 300074,China;Department of Pharmacy,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China;Department of Pulmonology,Children′s Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;Department of Pediatric Respiratory Medicine,the Second Affiliated Hospital&Yuying Children′s Hospital of Wenzhou Medical University,Wenzhou 325027,China;Department of Respiratory Medicine,Children′s Hospital of Nanjing Medical University,Nanjing 210008,China;Department of Respiratory Disease,Children′s Hospital of Fudan University,Shanghai 201102,China;Department of Respiratory Medicine,Shanghai Children′s Medical Center,School of Medicine,Shanghai Jiao Tong University,Shanghai 200062,China;Department of Respiratory Medicine,Wuhan Children′s Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430015,China)

机构地区：[1]国家儿童医学中心、国家呼吸疾病临床研究中心、首都医科大学附属北京儿童医院呼吸二科,北京100045 [2]四川大学华西第二医院小儿呼吸免疫科,成都610041 [3]上海交通大学医学院附属儿童医院呼吸科,上海200062 [4]上海交通大学医学院附属第一人民医院儿内科,上海200080 [5]重庆医科大学附属儿童医院呼吸科,重庆400014 [6]天津市儿童医院(天津大学儿童医院)马场院区呼吸科,天津300074 [7]国家儿童医学中心、首都医科大学附属北京儿童医院药学部,北京100045 [8]浙江大学医学院附属儿童医院呼吸科,杭州310052 [9]温州医科大学附属第二医院育英儿童医院儿童呼吸科,温州325027 [10]南京医科大学附属儿童医院呼吸科,南京210008 [11]复旦大学附属儿科医院呼吸科,上海201102 [12]上海交通大学医学院附属上海儿童医学中心呼吸科,上海200062 [13]华中科技大学同济医学院附属武汉儿童医院呼吸内科,武汉430015

出　　处：《中华儿科杂志》2024年第2期108-113,共6页Chinese Journal of Pediatrics

摘　　要：2023年肺炎支原体肺炎(MPP)在全国流行,国家卫生健康委员会于2023年2月发布“儿童肺炎支原体肺炎诊治指南”,但在实施过程中仍需要根据目前MPP特点,对重要诊治环节更加具体地指导和建议,现对MPP早期诊断方法、重症MPP判断依据和预警指标、各类抗支原体药物适应证、大环内酯类药物无反应性处理原则、糖皮质激素和支气管镜的应用问题等进行了专家释疑。

关 键 词：早期诊断方法 无反应性 儿童肺炎支原体肺炎 支气管镜 糖皮质激素 大环内酯类药物 预警指标 MPP 

分 类 号：R725.6[医药卫生—儿科]